FDA classifies Inventia Healthcare chlorthalidone recall as Class II

Widely used blood pressure medication recalled nationwide

Fox Business • 29 sept. 20h05

The FDA classified the recall of Inventia Healthcare's 25-mg chlorthalidone tablets as a Class II action after quality tests showed the tablets did not dissolve properly.

Popular blood pressure drug recalled over dissolution issues

New York Post • 29 sept. 13h49

Inventia Healthcare Limited is voluntarily recalling 13,567 bottles of 25 mg chlorthalidone tablets after FDA testing showed they did not meet dissolution standards, marking the company's second Class II recall this year.

FDA Announces New Nationwide Blood Pressure Medication Recall

Yahoo • 27 sept. 17h06

The FDA has designated a September recall of certain chlorthalidone tablets by Inventia Healthcare as a Class II recall, citing failed dissolution specifications.

FDA Announces New Nationwide Blood Pressure Medication Recall

Yahoo News Singapore • 27 sept. 17h06

The FDA has designated a September recall of certain chlorthalidone tablets by Inventia Healthcare as a Class II recall, citing failed dissolution specifications.

FDA Announces New Nationwide Blood Pressure Medication Recall

AOL.com • 27 sept. 17h06

The FDA has designated a September recall of Inventia Healthcare's chlorthalidone tablets as a Class II recall, citing failed dissolution specifications.

FDA Announces Recall on Blood Pressure Medication-More Than 13,000 Bottles Affected Nationwide

AOL.com • 24 sept. 16h34

The U.S. Food and Drug Administration has recalled more than 13,000 bottles of the blood-pressure drug chlorthalidone after dissolution tests failed, urging patients to consult their providers.